Navigation Links
GeckoSystems Successfully Applies Its Mobile Robot Solutions to Improve Wheelchair Safety
Date:11/8/2011

ms_SellsMobileRobotSolutions.php">http://www.geckosystems.com/investors/press_releases/20110317_GeckoSystems_SellsMobileRobotSolutions.php )

"The release of the Microsoft Kinect™ depth camera and its cost advantage over traditional machine vision solutions has helped the company further reduce the projected cost of the upgrade kit. This will make improved safety more affordable for thousands who presently rely on a wheelchair for personal mobility," reflected Spencer.

GeckoSteer™ is a new software and computer interface that was developed specifically for this application. It lies between the mechanical joystick and GeckoNav™, advanced automatic self-navigation software. GeckoSteer was needed to compensate for spasticity, tremor, and other involuntary movements associated with debilitating diseases that affect many wheelchair users.

It should be noted that GeckoSystems now has "proof of concept" for its proprietary suite of Mobile Robot Solutions for Safety, Security and Service™ which may be migrated to mobile platforms (as in the wheelchair) that were not originally designed to be under AI software navigation control. Using GeckoSystems' technology, the company expects many other market opportunities to open up for them in both the domestic and international marketplaces. The sale of collision proof safety upgrades for wheelchairs represents "low hanging fruit" that is ideal for GeckoSystems' entry into the retail market because of the large numbers of power wheelchairs in use and the need for safety upgrades that is expected to lead to rapid adoption in the market.

The Future:

"Now that we have a successful prototype of our 'collision proof' wheelchair upgrade kit, we will progress to visual design improvement and further cost reduction. We expect that technology-licensing revenues will precede revenues from product manufacturing and sales. We believe that our over 1300 stockholders wi
'/>"/>

SOURCE GeckoSystems International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeckoSystems CEO Does Live Interview on ChartPoppers.com About Mobile Robot Business Advancements
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
6. New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
7. NanoBio Corporation Successfully Completes Phase 2b Study in Herpes Labialis
8. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
9. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
10. Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children
11. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 2014 Molecular Profiles Ltd., a subsidiary of ... Maryland -based Xceleron have announced a ... clinical development that will be launched at AAPS in ... This partnership extends Molecular Profiles, new ROADMAP to ... this month. The company also has complementary collaborations in ...
(Date:10/30/2014)... 30, 2014  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced an upcoming presentation ... candidate, aldoxorubicin.  The presentation, titled, "Drug Conjugates Bind ... given by Sant P. Chawla , M.D., ... principal investigator of the Company,s ongoing global, pivotal ...
(Date:10/30/2014)... October 30, 2014 , ... LGG contribuye a adquirir tolerancia a la proteína ... la proteína de la leche de la vaca (APLV) ... infancia. Hasta ahora, la APLV se trataba eliminando ... ha demostrado que es posible adquirir tolerancia oral ...
Breaking Medicine Technology:Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3
... Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO ) today reported ... Total revenue was $2.4 million and $5.5 million for the three ... $2.5 million for the same periods in 2010. Total ... 2011, were $7.6 million and $15.0 million as compared to $6.1 ...
... 2011 CORRECTED -- Bionovo, Inc. (NASDAQ: BNVI ... the three months ended June 30, 2011. ... drug candidate, MF101, or Menerba™, during the past quarter, delivering ... and Chief Executive Officer. "We have completed the tasks which ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 9Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 10Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 11CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 2CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 3CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 4CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 5
(Date:10/30/2014)... Horse Sense & Sensitivity ... special needs individuals in the Jacksonville area, will be ... from 10-2:00 p.m. at Bailey's Farm (2202 Bishop Estates ... public and is designed to raise awareness and funds ... HSS Round-Up is free. Ticket purchases will be required ...
(Date:10/30/2014)... New York (PRWEB) October 30, 2014 ... Society (NAMS) came to a close on Saturday, ... meeting since the Society’s inception in 1989. NAMS is ... health and quality of life of all women during ... healthy aging. With over 2,000 physicians and thought leaders ...
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, 2014 (HealthDay ... may have effects on genital development in baby boys, a ... to moms with greater exposure to a chemical called DiNP ... between the genitals and anus. Anogenital distance is set in ... androgens ("male" hormones) during pregnancy. The researchers said their ...
(Date:10/30/2014)... Oct. 29, 2014 (HealthDay News) -- A new vaccine ... meningococcal disease was approved by the U.S. Food and ... protect people between the ages of 10 and 25 ... serogroup B bacteria. The bacteria can infect ... spinal cord and brain. It is a leading cause ...
(Date:10/29/2014)... A new study has found that certain prostate cancer ... from heart-related causes in men with congestive heart failure ... , the findings will help doctors and patients weigh ... Androgen deprivation therapy (ADT), which reduces levels of male ... cancer cells, is a mainstay of treatment for prostate ...
Breaking Medicine News(10 mins):Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 3Health News:FDA Approves New Vaccine to Protect Against Meningitis 2Health News:Prostate cancer medications linked with increased risk of heart-related deaths in men with cardiovascular problems 2
... ... ... company that launched the first FDA cleared Fourier/spectral domain OCT in the US, announced its ... , ,“Following our 19% revenue growth in 2009 over 2008, we expected the economy and ...
... Emergency services double ... ... announced ambitious plans to add a second inpatient tower to meet what has become an enormous ... beds, more emergency care and more jobs to the Anschutz Medical Campus and the state., , ...
... ... inspire, motivate and empower members of the healthcare team and the patients and family members ... calling for entries now, with winners announced later this year. , ... Rockville, MD (PRWEB) May 24, 2010 -- Dorland ...
... PLoS ONE, Massachusetts General Hospital (MGH) ... individuals unconsciously distribute their preferences regarding approaching or ... appear to meet the strict criteria used to ... if confirmed in future studies, could potentially be ...
... patients with transformed lymphoma showed "remarkable" response to lenalidomide, ... international study, involving 24 medical centers in the United ... Society of Clinical Oncology ( http://www.asco.org/ ) annual meeting ... of patients with transformed lymphoma treated with lenalidomide responded ...
... triggers the need for a night,s rest may be the ... Brain injuries can disrupt the body,s production of the hormone ... , "We,ve known that people often have problems with sleep ... the exact causes of these problems," study author Shantha Rajaratnam ...
Cached Medicine News:Health News:Optovue Q1 2010 Revenue Up 57% Over Same Quarter 2009 2Health News:,University of Colorado Hospital Moving Forward with $400 Million Expansion, 2Health News:,University of Colorado Hospital Moving Forward with $400 Million Expansion, 3Health News:Dorland Health Announces People Awards Honoring Excellence & Dedication Among Healthcare Professionals - Call For Entries 2Health News:Study finds 'law-like' patterns in human preference behavior 2Health News:Study finds 'law-like' patterns in human preference behavior 3Health News:Study identifies promising treatment for aggressive lymphoma 2Health News:Brain Injuries May Lead to Sleep Woes 2
... Ankle Orthosis enables the clinician to ... ankle joint to control muscle imbalance ... a pair of bilateral turnbuckles, controlling ... Simply adjust the turnbuckle to gradually ...
... Protection,Protects the heel while maintaining the ankle ... contact with a soft, cushioning AliPlast™ foam ... and liner cradles the heel in a ... change position freely in bed from side-lying ...
... Pediatric Ankle Cryo/Cuff is specifically designed to ... Using a combination of controlled compression and ... pain. The Pediatric Ankle Cryo/Cuff is ideal ... episodes in hemophilia.,The Pediatric Ankle Cryo/Cuff is ...
SCD Sequential Compression System Intermittent Pneumatic Compression...
Medicine Products: